CRKL, ETV6 acts as tumor promotors and miR-429 acts as a tumor suppressor in HCC, their dysexpressions are involved in the carcinogenesis and progression of hepatocarcinoma. The gene discussed is CRKL; the disease is hepatocellular carcinoma.